Folgen
Edouard Louis
Edouard Louis
University Liege
Bestätigte E-Mail-Adresse bei ulg.ac.be
Titel
Zitiert von
Zitiert von
Jahr
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
L Jostins, S Ripke, RK Weersma, RH Duerr, DP McGovern, KY Hui, ...
Nature 491 (7422), 119-124, 2012
5178*2012
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
JC Barrett, S Hansoul, DL Nicolae, JH Cho, RH Duerr, JD Rioux, SR Brant, ...
Nature genetics 40 (8), 955-962, 2008
31862008
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
A Franke, DPB McGovern, JC Barrett, K Wang, GL Radford-Smith, ...
Nature genetics 42 (12), 1118-1125, 2010
30982010
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47
CA Anderson, G Boucher, CW Lees, A Franke, M D'Amato, KD Taylor, ...
Nature genetics 43 (3), 246-252, 2011
16682011
The second European evidence-based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis
G Van Assche, A Dignass, J Panes, L Beaugerie, J Karagiannis, M Allez, ...
Journal of Crohn's and Colitis 4 (1), 7-27, 2010
13332010
Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease
E Louis, A Collard, AF Oger, E Degroote, FAN El Yafi, J Belaiche
Gut 49 (6), 777-782, 2001
11832001
Two stage genome–wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12
J Satsangi, M Parkes, E Louis, L Hashimoto, N Kato, K Welsh, ...
Nature genetics 14 (2), 199-202, 1996
9241996
Tumour necrosis factor (TNF) gene polymorphism influences TNF‐α production in lipopolysaccharide (LPS)‐stimulated whole blood cell culture in healthy humans
Louis, Franchimont, Piron, Gevaert, Roland, Mahieu, Malaise, DE Groote, ...
Clinical & Experimental Immunology 113 (3), 401-406, 1998
8181998
Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped
E Louis, JY Mary, G Vernier–Massouille, JC Grimaud, Y Bouhnik, ...
Gastroenterology 142 (1), 63-70. e5, 2012
7052012
Development of the Crohn's disease digestive damage score, the Lemann score
B Pariente, J Cosnes, S Danese, WJ Sandborn, M Lewin, JG Fletcher, ...
Inflammatory bowel diseases 17 (6), 1415-1422, 2011
6952011
Mapping the human genetic architecture of COVID-19
Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ...
Nature 600 (7889), 472-477, 2021
6862021
Novel Crohn Disease Locus Identified by Genome-Wide Association Maps to a Gene Desert on 5p13.1 and Modulates Expression of PTGER4
C Libioulle, E Louis, S Hansoul, C Sandor, F Farnir, D Franchimont, ...
PLoS genetics 3 (4), e58, 2007
6762007
Fine-mapping inflammatory bowel disease loci to single-variant resolution
H Huang, M Fang, L Jostins, M Umićević Mirkov, G Boucher, ...
Nature 547 (7662), 173-178, 2017
5702017
Common variants in the NLRP3 region contribute to Crohn's disease susceptibility
AC Villani, M Lemire, G Fortin, E Louis, MS Silverberg, C Collette, N Baba, ...
Nature genetics 41 (1), 71-76, 2009
5692009
Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial
JP Galmiche, J Hatlebakk, S Attwood, C Ell, R Fiocca, S Eklund, ...
Jama 305 (19), 1969-1977, 2011
5582011
Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled …
BG Feagan, WJ Sandborn, G D'Haens, J Panés, A Kaser, M Ferrante, ...
The Lancet 389 (10080), 1699-1709, 2017
4452017
Predictors of severe Crohn's disease
C Loly, J Belaiche, E Louis
Scandinavian journal of gastroenterology 43 (8), 948-954, 2008
3862008
Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after ileo-caecal …
A Van Gossum, O Dewit, E Louis, G de Hertogh, F Baert, F Fontaine, ...
Inflammatory bowel diseases 13 (2), 135-142, 2007
3762007
Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspects
M Allez, K Karmiris, E Louis, G Van Assche, S Ben-Horin, A Klein, ...
Journal of Crohn's and Colitis 4 (4), 355-366, 2010
3702010
Genetic markers may predict disease behavior in patients with ulcerative colitis
M Roussomoustakaki, J Satsangi, K Welsh, E Louis, G Fanning, S Targan, ...
Gastroenterology 112 (6), 1845-1853, 1997
3511997
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20